Angioblast Systems Incorporated – Trademark Portfolio
Entity Type: 03
Angioblast Systems Incorporated holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include REVASCOR. The owner is based in New York, NY.
275 Madison Avenue, 4th Floor
New York, NY 10016
Showing of trademarks Trademarks
Trademark Classifications
Angioblast Systems Incorporated's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Angioblast Systems Incorporated have?
Angioblast Systems Incorporated has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Angioblast Systems Incorporated file in?
Angioblast Systems Incorporated files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Angioblast Systems Incorporated's most well-known trademarks?
Angioblast Systems Incorporated's registered trademark portfolio includes well-known marks such as REVASCOR. These are among 1 currently registered trademark in the portfolio.
What is Angioblast Systems Incorporated's trademark registration success rate?
Angioblast Systems Incorporated has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.